Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
出版年份 2018 全文链接
标题
Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
作者
关键词
-
出版物
MOLECULES
Volume 23, Issue 11, Pages 2906
出版商
MDPI AG
发表日期
2018-11-09
DOI
10.3390/molecules23112906
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- cRGD functionalised nanocarriers for targeted delivery of bioactives
- (2018) K. R. Gajbhiye et al. JOURNAL OF DRUG TARGETING
- iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
- (2017) Fei Gao et al. International Journal of Nanomedicine
- Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery
- (2017) Jia-Lin Huang et al. JOURNAL OF DRUG TARGETING
- Co-delivery of hydrophilic gemcitabine and hydrophobic paclitaxel into novel polymeric micelles for cancer treatment
- (2017) Yan Di et al. RSC Advances
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- Cost-Utility of "Doxorubicin and Cyclophosphamide" versus "Gemcitabine and Paclitaxel" for Treatment of Patients with Breast Cancer in Iran
- (2016) Nahid Hatam et al. Asian Pacific Journal of Cancer Prevention
- Incidence and Mortality and Epidemiology of Breast Cancer in the World
- (2016) Mahshid Ghoncheh et al. Asian Pacific Journal of Cancer Prevention
- Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment
- (2016) DongMei Yu et al. BIOMEDICINE & PHARMACOTHERAPY
- The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate
- (2016) Xiang Li et al. International Journal of Nanomedicine
- Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line
- (2016) Xinzhe Yu et al. Scientific Reports
- Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy
- (2016) Chandran Murugan et al. Scientific Reports
- Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
- (2015) Huan Meng et al. ACS Nano
- Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer
- (2015) Ilkoo Noh et al. BIOMATERIALS
- Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?
- (2015) Michelle M. Williams et al. Oncotarget
- Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer
- (2014) Lei Miao et al. ADVANCED FUNCTIONAL MATERIALS
- Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer
- (2014) Ping Chen et al. CANCER SCIENCE
- Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model
- (2014) Jing Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates
- (2014) R. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumour targeting of lipid nanocapsules grafted with cRGD peptides
- (2013) Samuli Hirsjärvi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The Functions and Applications of RGD in Tumor Therapy and Tissue Engineering
- (2013) Fen Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02
- (2013) Yeon Hee Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC
- (2013) Yuan Zhang et al. MOLECULAR THERAPY
- Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles
- (2011) Sandy Vrignaud et al. BIOMATERIALS
- PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
- (2011) Ganta Chaitanya et al. Cell Communication and Signaling
- In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles
- (2011) Brian R. Sloat et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Mechanism of Inactivation of Human Ribonucleotide Reductase with p53R2 by Gemcitabine 5′-Diphosphate
- (2009) Jun Wang et al. BIOCHEMISTRY
- Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
- (2009) Jun Li et al. JOURNAL OF CONTROLLED RELEASE
- Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment
- (2008) Kathy S. Albain et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started